Skyrizi 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F5F2T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,800
Award facts
- Contract value 100% obligated
- $36,799.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,799.76 to AmerisourceBergen Drug Corp for the supply of Skyrizi 150 mg/ml syringes. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and employs firm fixed price terms. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. No set-aside designation was applied to this award, indicating it was competitively awarded through open procurement processes.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills critical medical supply needs for the federal government, particularly supporting military and veteran healthcare systems. The company's SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support defense and health agency customers worldwide. This particular delivery order for Skyrizi, a biologic pharmaceutical, is consistent with AmerisourceBergen's extensive portfolio of federal pharmaceutical procurement across the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F5F2T?
SPE2DR26F5F2T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F5F2T worth?
The government has obligated $36,800 on SPE2DR26F5F2T.
Is contract SPE2DR26F5F2T an order under another contract?
Yes. SPE2DR26F5F2T is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F2T competed?
The extent of competition for SPE2DR26F5F2T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award